Introducing the hormonal Intrauterine Device in Madagascar, Nigeria, and Zambia: results from a pilot study

被引:5
|
作者
Danna, Kendal [1 ]
Jaworski, Grace [1 ]
Rahaivondrafahitra, Bakoly [2 ]
Rasoanirina, Francia [2 ]
Nwala, Anthony [3 ]
Nqumayo, Masauso [4 ]
Smith, Gina [4 ]
Moon, Pierre [1 ]
Jackson, Ashley [1 ,5 ]
Thurston, Sarah [1 ]
Kalamar, Amanda [1 ]
机构
[1] Populat Serv Int PSI, 1120 19th St NW 600, Washington, DC 20036 USA
[2] PSI Madagascar Immeuble Arboretumex Village Jeux, Antananarivo 101, Madagascar
[3] Soc Family Hlth SFH Nigeria, Justice Ifeyinwa Nzeako House, Abuja, Nigeria
[4] SFH Zambia, Plot 549 Ituna Rd, Lusaka, Zambia
[5] WCG Cares, 12400 High Bluff Dr,Suite 600, San Diego, CA 92130 USA
关键词
Hormonal IUD; Hormonal IUS; LNG-IUS; LARC; Continuation; Satisfaction; Acceptability; SATISFACTION;
D O I
10.1186/s12978-021-01300-x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background The hormonal Intrauterine Device (IUD) is a highly effective contraceptive option growing in popularity and availability in many countries. The hormonal IUD has been shown to have high rates of satisfaction and continuation among users in high-income countries. The study aims to understand the profiles of clients who choose the hormonal IUD in low- and middle-income countries (LMICs) and describe their continuation and satisfaction with the method after 12 months of use. Methods A prospective longitudinal study of hormonal IUD acceptors was conducted across three countries-Madagascar, Nigeria, and Zambia-where the hormonal IUD had been introduced in a pilot setting within the of a broad mix of available methods. Women were interviewed at baseline immediately following their voluntary hormonal IUD insertion, and again 3 and 12 months following provision of the method. A descriptive analysis of user characteristics and satisfaction with the method was conducted on an analytic sample of women who completed baseline, 3-month, and 12-month follow-up questionnaires. Kaplan-Meier time-to-event models were used to estimate the cumulative probability of method continuation rates up to 12 months post-insertion. Results Each country had a unique demographic profile of hormonal IUD users with different method-use histories. Across all three countries, women reported high rates of satisfaction with the hormonal IUD (67-100%) and high rates of continuation at the 12-month mark (82-90%). Conclusions Rates of satisfaction and continuation among hormonal IUD users in the study suggest that expanding method choice with the hormonal IUD would provide a highly effective, long-acting method desirable to many different population segments, including those with high unmet need. Plain language summary The hormonal IUD is a popular contraceptive method choice where it is available. While the method has been around for decades it remains out of reach for many populations in low- and middle-income countries. The hormonal IUD offers both highly effective protection from pregnancy as well as non-contraceptive benefits that appeal to users in the US and Europe, but there is limited evidence available to explore the acceptability and use of this method among users in lower resource settings. This research looks at the profile of users who chose to use the hormonal IUD during a pilot introduction in Madagascar, Nigeria, and Zambia. Over a period of 12 months, researchers followed up with these users to understand who continued to use the method over time and their satisfaction with the method. Findings show that the hormonal IUD was broadly appealing in these settings among users from multiple demographic segments, including among users who had not used other methods of contraception in the past. When followed-up at 3 and 12 months, satisfaction with the method was high and most users in all three countries were still using the method. The findings suggest that the hormonal IUD could be well received and may contribute to greater uptake of voluntary modern contraception in lower resource settings.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Introducing the hormonal Intrauterine Device in Madagascar, Nigeria, and Zambia: results from a pilot study
    Kendal Danna
    Grace Jaworski
    Bakoly Rahaivondrafahitra
    Francia Rasoanirina
    Anthony Nwala
    Masauso Nqumayo
    Gina Smith
    Pierre Moon
    Ashley Jackson
    Sarah Thurston
    Amanda Kalamar
    [J]. Reproductive Health, 19
  • [2] Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia
    Brunie, Aurelie
    Stankevitz, Kayla
    Nwala, Anthony Adindu
    Nqumayo, Masauso
    Chen, Mario
    Danna, Kendal
    Afolabi, Kayode
    Rademacher, Kate H.
    [J]. LANCET GLOBAL HEALTH, 2021, 9 (10): : E1431 - E1441
  • [3] NEW INTRAUTERINE DEVICE - PILOT STUDY
    ESPOSITO, JM
    ZAROU, D
    PERTICUC.S
    ZAROU, G
    [J]. NEW YORK STATE JOURNAL OF MEDICINE, 1967, 67 (24) : 3242 - &
  • [4] Expanding Contraceptive Method Choice With a Hormonal Intrauterine System: Results From Mixed Methods Studies in Kenya and Zambia
    Sitrin, Deborah
    Pfitzer, Anne
    Ndirangu, Gathari
    Kamanga, Ameck
    Onguti, Brenda
    Ontiri, Susan
    Chilambwe, Jully
    Kabwe, Victor
    Aladesanmi, Lola
    Elliott, Leah
    Bhatnagar, Neeta
    [J]. GLOBAL HEALTH-SCIENCE AND PRACTICE, 2021, 9 (01): : 89 - 106
  • [5] INTRAUTERINE CONTRACEPTIVE DEVICE - REPORT OF A PILOT STUDY
    ROBINSON, SC
    MARTIN, TR
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 1967, 97 (04) : 174 - &
  • [6] Fertility after Intrauterine Device Removal: A Pilot Study
    Stoddard, Amy M.
    Xu, Hanna
    Madden, Tessa
    Allsworth, Jenifer E.
    Peipert, Jeffrey F.
    [J]. EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2015, 20 (03): : 223 - 230
  • [7] Association between intrauterine device type and risk of perforation and device expulsion: results from the Association of Perforation and Expulsion of Intrauterine Device study
    Gatz, Jennifer L.
    Armstrong, Mary Anne
    Postlethwaite, Debbie
    Raine-Bennett, Tina
    Chillemi, Giulia
    Alabaster, Amy
    Merchant, Maqdooda
    Reed, Susan D.
    Ichikawa, Laura
    Getahun, Darios
    Fassett, Michael J.
    Shi, Jiaxiao M.
    Xie, Fagen
    Chiu, Vicki Y.
    Im, Theresa M.
    Takhar, Harpreet S.
    Wang, Jinyi
    Saltus, Catherine W.
    Ritchey, Mary E.
    Asiimwe, Alex
    Pisa, Federica
    Schoendorf, Juliane
    Wahdan, Yesmean
    Zhou, Xiaolei
    Hunter, Shannon
    Anthony, Mary S.
    Peipert, Jeffrey F.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 227 (01) : 57.e1 - 57.e13
  • [8] Hormonal intrauterine device in women with renal transplantation: a prospective observational study
    Amado, Fernanda Costa
    de Oliveira, Anelisa Pinotti
    Hamamoto, Tatiana Emy Nishimoto Kawanami
    Araujo, Edward
    Guazzelli, Cristina Aparecida Falbo
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2023, 69 (10):
  • [9] RANDOMIZING WOMEN TO INTRAUTERINE DEVICE TYPE: A PILOT STUDY EXPERIENCE
    Achilles, S.
    Chen, B.
    Gariepy, A.
    Creinin, M.
    [J]. CONTRACEPTION, 2012, 86 (03) : 318 - 319
  • [10] The Role of the Mirena Intrauterine Device in the Management of Endometrial Polyps: A Pilot Study
    Chowdary, Prathima
    Maher, Peter
    Ma, Tony
    Newman, Marsali
    Ellett, Lenore
    Readman, Emma
    [J]. JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2019, 26 (07) : 1297 - 1302